Leslie Kristina M sold $106K of HNGE

Leslie Kristina M sold 1,200 shares of Hinge Health, Inc. (HNGE) at $88.23 ($0.11M total) on 2026-08-20.

Original reporting
SEC EDGAR · Leslie Kristina M
Published Aug 21, 2026, 10:47 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 21, 2026, 10:55 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$HNGE
Neutral
low confidence
Mentioned
$HNGE
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$HNGENeutralLow
01

Why it matters

The transaction is small and unlikely to affect the stock price materially.

02

Market read

Minor insider sale with limited trading relevance.

03

What to watch

Potential upcoming financing round or employee stock plan that may affect future insider transactions.

Relevance 4/10Novelty 4/10Timing: post‑market today

Background

Form 4 filings disclose insider trades; this filing reports a director's sale of Hinge Health shares.

Company-level read

Ticker impact

$HNGENeutralLow confidence
Context

Director Leslie Kristina M sold 1,200 shares of Hinge Health for $105,876 on 2026-08-20.

Expected impact

Minimal short‑term price pressure, likely within normal volatility range.

Evidence & confidence

The sale represents less than 4% of the insider's remaining stake and is under $0.2M, which typically does not move the market.

Market effects

No material impact on the digital health sector.

Limited to investors tracking insider activity.

Negligible.

Counterpoint

The sale could be a routine liquidity event rather than a negative signal.

Key entities

  • Hinge Health, Inc.

    Digital health company focused on musculoskeletal care.

  • Leslie Kristina M

    Board member of Hinge Health.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$HNGEHighAI 8/10

Needham raises Hinge Health stock price target on client growth

Needham raised its price target for Hinge Health (NYSE:HNGE) to $135 from $115, citing strong client growth and quarterly performance. The company reported 28% year-over-year client growth, 50% revenue increase, and 154% stock return over six months. Q3 revenue was $235 million, up 52% year-over-year, with EPS of $0.66 beating estimates. Wells Fargo also raised its target to $132, noting strong margins and revenue growth.

$HNGEHighAI 8/10

Hinge Health (HNGE) Q3 2026 Earnings Call Transcript

Hinge Health (HNGE) reported Q3 2026 revenue of $235M, up 52% YoY, with gross margin at 88% and operating income at $77M. The company highlighted growth in its MSK, Migraine, and GI care programs, with strong early results in Migraine care. President Jim Pursley announced his departure at year-end to spend more time with family but will join the board.